Simulations Plus (SLP) Partners with Large Pharmaceutical Company to Advance ADMET Predictor Machine Learning Software
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Simulations Plus (SLP) Misses Q2 EPS by 2c, Revenues Beat
April 9, 2020 4:47 PM EDTSimulations Plus (NASDAQ: SLP) reported Q2 EPS of $0.12, $0.02 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $9.86 million.
2QFY20 highlights compared with 2QFY19:
Net revenues increased 22.2%, or $1.9 million, to $10.3 million from $8.5 millionGross profit was $7.7 million, up $1.4 million, or 22.7%, from $6.3 millionSG&A was $4.1 million, up $1.3 million, or 46.3%, from $2.8 millionSG&A as a percentage of revenues increased to 39.7% from 33.2%, inclusive of $350,000 in transaction costs related to the Lixoft acquisitionR&D expense increased 3.3%, or $23,600, to $748,000 from $724,000Income before taxes increased 5.2%, or $140,500, to... More